Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.2.1.31 (
beta-glucuronidase
)
7,680
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Like most psychoactive agents, cannabis and its active component
delta-9-tetrahydrocannabinol
(delta
9-THC
) have been reported to affect the neuroendocrine axis in animals. The effect of delta
9-THC
on some of the functionally important enzymes of the male reproductive organs are reported. The study indicates that delta
9-THC
reduces the activities of the enzymes,
beta-glucuronidase
, alpha-glucosidase acid phosphatase and fructose-6-phosphatase in a dose related manner in the testis, prostate as well as in the epididymis. It may be concluded that delta
9-THC
may interfere with the normal functioning of the male reproductive organs.
...
PMID:Enzymatic changes in the male reproductive organs by delta-9-tetrahydrocannabinol. 628 Jul 29
This report describes a method for the quantitative analysis of delta
9-tetrahydrocannabinol
and six of its metabolites, 8 alpha-hydroxy-delta
9-tetrahydrocannabinol
, 8 beta-hydroxy-delta
9-tetrahydrocannabinol
, 11-hydroxy-delta
9-tetrahydrocannabinol
, 8 alpha,11-dihydroxy-delta
9-tetrahydrocannabinol
, 8 beta,11-dihydroxy-delta
9-tetrahydrocannabinol
, and 11-nor-9-carboxy-delta
9-tetrahydrocannabinol
. In addition, the method was designed to detect cannabidiol and cannabinol, two naturally occurring cannabinoids. Plasma and urine samples were hydrolyzed with bacterial (Escherichia coli)
beta-glucuronidase
and extracted with hexane-ethyl acetate (7:1). Analysis and quantitation were performed by gas chromatography-mass spectrometry in the electron ionization mode coupled with selected ion monitoring. The cannabinoids were detected as their trimethylsilyl derivatives to enhance their chromatographic separation and mass spectral characteristics. The linearity of the procedure was excellent for all of the compounds within the range tested (0-100 ng/mL). Limits of detection ranged from 0.5 to 1.5 ng/mL in urine and from 0.6 to 2.1 ng/mL in plasma depending on the analyte.
...
PMID:Cannabinoids in humans. I. Analysis of delta 9-tetrahydrocannabinol and six metabolites in plasma and urine using GC-MS. 750 Jun 14